Physician profile
Max Epstein
NPI 1801328901
$3,555.78
in general payments reported to CMS, 2019-2025
12 companies · $51.89 in 2025
The $51.89 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,253 · 2022: $41.82 · 2023: $909 · 2024: $1,299 · 2025: $51.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,831 · Travel and Lodging: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,830.87 |
| Travel and Lodging | $429.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $740.37 | 2021-2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $686.21 | 2024 | Intracept |
| Spr Therapeutics, INC | $551.33 | 2021-2025 | Sprint Pns System |
| Abbott Laboratories | $512.01 | 2021-2024 | Proclaim |
| Vertos Medical, INC. | $344.03 | 2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $325.44 | 2023 | Evoke Scs |
| Aveo Pharmaceuticals, INC. | $134.87 | 2021 | |
| Nevro Corp. | $101.48 | 2021 | |
| Relievant Medsystems, INC. | $50.15 | 2023 | Intracept |
| Stryker Corporation | $45.84 | 2021 | |
| Curonix LLC | $41.82 | 2022 | |
| Allergan, INC. | $22.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.